"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESThe infant formula industry is at a crossroads, facing intense scrutiny over health claims and marketing practices. With a global market value of approximately $54 billion, the stakes are high for manufacturers to substantiate their claims with solid scientific evidence.
Health claims on infant formula packaging are not mere marketing ploys; they are promises of nutritional benefits that support an infant's growth and development. These claims range from supporting brain development and immune system function to mimicking breast milk's nutritional profile. However, the challenge lies in the rigorous scientific validation required to back these claims. This process involves ethical considerations, methodological complexities, and regulatory hurdles that manufacturers must navigate.
Addressing these challenges requires a strategic approach. Our up-coming white paper - Navigating Challenges in Marketing Infant Nutrition Products - will offer a deeper dive into what industry can do to overcome these challenges, but key areas of focus should be: enhancing research integrity, adopting innovative methodologies, engaging with stakeholders, and establishing standardized global regulations. The goal is to align research objectives with public health goals, promote ethical marketing practices, and ensure consumers can make informed decisions.
To support these recommendations, the industry can now also leverage emerging technologies. Advanced data analytics, including machine learning algorithms, are becoming instrumental in analyzing complex datasets related to infant nutrition. These tools can uncover patterns and correlations that traditional statistical methods might miss, providing deeper insights into the effects of various components of infant formulas on growth and development. Additionally, integrating social media listening strategies with generative artificial intelligence or natural language processing tools can help understand the sentiments and needs of parents and caregivers. Such insights are invaluable for refining study protocols, recruitment strategies, and educational campaigns, thereby enhancing engagement with the target audience.
A decentralized clinical trial conducted by IQVIA Consumer Health offers a glimpse into the future of infant formula research. The trial, which studied the growth patterns of infants fed with a new goat milk-based formula, leveraged digital tools for remote data collection, allowing for greater inclusivity and convenience for participants.
As the industry navigates these challenges, it is clear that a harmonized global approach and the adoption of advanced technologies will be pivotal in shaping the future of infant nutrition research. By embracing these changes, the industry can ensure that infant formula remains a safe, effective, and trusted source of nutrition for babies worldwide.
Hit the CONTACT US button floating on this page for support from IQVIA Consumer Health on optimal study design, planning, execution, and regulatory compliance.
